|
|
Hiroshi Hata, Noriko Sakaguchi, Hiroyuki Yoshitomi, Yoichiroh Iwakura, Kenji Sekikawa, Yoshiaki Azuma, Chieko Kanai, Eiko Moriizumi, Takashi Nomura, Takashi Nakamura, Shimon Sakaguchi
J Clin Invest. 2004;
114(4):582
doi:10.1172/JCI21795
Abstract |
Full text
| PDF
| Supplemental material

C
ytokines play key roles in spontaneous CD4+ T cell–mediated chronic autoimmune arthritis in SKG mice, a new model of rheumatoid arthritis. Genetic deficiency in IL-6 completely suppressed the development of arthritis in SKG mice, irrespective of the persistence of circulating rheumatoid factor. Either IL-1 or TNF-α deficiency retarded the onset of arthritis and substantially reduced its incidence and severity. IL-10 deficiency, on the other hand, exacerbated disease, whereas IL-4 or IFN-γ deficiency did not alter the disease course. Synovial fluid of arthritic SKG mice contained high amounts of IL-6, TNF-α, and IL-1, in accord with active transcription of these cytokine genes in the afflicted joints. Notably, immunohistochemistry revealed that distinct subsets of synovial cells produced different cytokines in the inflamed synovium: the superficial synovial lining cells mainly produced IL-1 and TNF-α, whereas scattered subsynovial cells produced IL-6. Thus, IL-6, IL-1, TNF-α, and IL-10 play distinct roles in the development of SKG arthritis; arthritogenic CD4+ T cells are not required to skew to either Th1 or Th2; and the appearance of rheumatoid factor is independent of joint inflammation. The results also indicate that targeting not only each cytokine but also each cell population secreting distinct cytokines could be an effective treatment of rheumatoid arthritis.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(25)
| Title and authors |
Publication |
Year |
In vivo RNAi-mediated silencing of TAK1 decreases inflammatory Th1 and Th17 cells through targeting of myeloid cells
G. Courties, V. Seiffart, J. Presumey, V. Escriou, D. Scherman, J. Zwerina, G. Ruiz, N. Zietara, J. Jablonska, S. Weiss, A. Hoffmann, C. Jorgensen, F. Apparailly, G. Gross
|
Blood
|
2010 |
Effect of the C3a-Receptor Antagonist SB 290157 on Anti-OVA Polyclonal Antibody–Induced Arthritis
Pilaiwanwadee Hutamekalin, Kohei Takeda, Mitsuhiro Tani, Yuko Tsuga, Naoki Ogawa, Nobuaki Mizutani, Shin Yoshino
|
J Pharmacol Sci
|
2010 |
Cytokine-dependent but acquired immunity-independent arthritis caused by DNA escaped from degradation.
Kohki Kawane, Hiromi Tanaka, Yusuke Kitahara, Shin Shimaoka, Shigekazu Nagata
|
Proc. Natl. Acad. Sci. U.S.A.
|
2010 |
Interleukin 6 in autoimmune and inflammatory diseases: a personal memoir
Toshio HIRANO
|
Proc. Jpn. Acad., Ser. B
|
2010 |
The recombinant humanized anti-IL-6 receptor antibody tocilizumab, an innovative drug for the treatment of rheumatoid arthritis
Yoshiyuki Ohsugi, Tadamitsu Kishimoto
|
Expert Opin. Biol. Ther.
|
2008 |
Increased Responsiveness to Toll-Like Receptor 4 Stimulation in Peripheral Blood Mononuclear Cells from Patients with Recent Onset Rheumatoid Arthritis
M. L. Kowalski, A. Wolska, J. Grzegorczyk, J. Hilt, M. Jarzebska, M. Drobniewski, M. Synder, M. Kurowski
|
Mediators of Inflammation
|
2008 |
Tocilizumab, a Humanized Anti-interleukin-6 Receptor Antibody, Ameliorates Joint Swelling in Established Monkey Collagen-Induced Arthritis
Yasushi Uchiyama, Keigo Yorozu, Misato Hashizume, Yoichiro Moriya, Masahiko Mihara
|
Biol. Pharm. Bull.
|
2008 |
Spleen tyrosine kinase: a novel target for therapeutic intervention of rheumatoid arthritis
Malini Bajpai, Puneet Chopra, Sunanda G Dastidar, Abhijit Ray
|
Expert Opin. Investig. Drugs
|
2008 |
Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production.
Salahuddin Ahmed, Hubert Marotte, Kevin Kwan, Jeffrey H Ruth, Phillip L Campbell, Bradley J Rabquer, Angela Pakozdi, Alisa E Koch
|
Proc. Natl. Acad. Sci. U.S.A.
|
2008 |
Arthritis and pneumonitis produced by the same T cell clones from mice with spontaneous autoimmune arthritis
C. Wakasa-Morimoto, T. Toyosaki-Maeda, T. Matsutani, R. Yoshida, S. Nakamura-Kikuoka, M. Maeda-Tanimura, H. Yoshitomi, K. Hirota, M. Hashimoto, H. Masaki, Y. Fujii, T. Sakata, Y. Tsuruta, R. Suzuki, N. Sakaguchi, S. Sakaguchi
|
International Immunology
|
2008 |
|